Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RUBCN | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | RUNDC3B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | PFKFB4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AC017028.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ICAM3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | CCSAP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | LTBP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | BRCA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | U2AF1L4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ANKRD13A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |